ArticleJBMR plus2026

Effectiveness, safety, and pharmacokinetics of burosumab in Chinese children with X-linked hypophosphatemia: an open-label, single-arm phase 4 study.

Wei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.